 |
 |
I am concerned What is the evidence for this activity? What are the benefits and costs. If I am to enable twitter which undoubtedly will take time what is the absolute benefit to me in terms of evidology?. Will I become more competent – knowledge skills and attitude - if I use this compared to web browsing using a bit of both push and pull technologies. What is the added value? Isn't this an opportunity for a study? Martin On 30/07/2009 11:50, "BENTLEY, Annabel" <[log in to unmask]> wrote: Following numbers: - 300ish: possible if you are regularly on Blackberry or i-phone and use a Twitter app (it's a bit like being at a conference with lots of conversations going on) - 50ish: perhaps more suitable if you only login via PC some of the time (this is more like being linked to a department of colleagues) I will try the evidence-based twibe when I have a chance best wishes Annabel ________________________________ From: Evidence based health (EBH) [mailto:[log in to unmask]] On Behalf Of carl heneghan Sent: 30 July 2009 15:15 To: [log in to unmask] Subject: Re: tweeting Dear all good to see your all upto date with tweeting couple of things I found useful in Ami and my early learning curve at trustthevidence.net <http://trustthevidence.net> 1) use some of the useful applications to manage your tweets these include: tweetdeck http://tweetdeck.com/beta/ if your a firefox user the twtterfox https://addons.mozilla.org/en-US/firefox/addon/5081 both of these automatcially sync with twitter and make the experience much better 2) We ve found following more that 50 people to much to handle, and We've chopped and changed them to suit our interests. One strategy some people use is to follow 1000 hoping they will follow them back. Completely useless as it means no one is following anyone 3) Weve also set up an evidence based twibe at http://www.twibes.com/group/evidence-based?id=2961096 if you join it means any of your twitters (and the members) with evidence-based or eivdence in the body of the twitter will be located here and easily accesible Cheers Carl http://twitter.com/cebmblog 2009/7/30 Pawin Numthavaj <[log in to unmask]> Hello, I'm a grad student in Clin. Epi & EBM, here's my account: http://twitter.com/pawinpawin Cheers, Pawin Numthavaj Ramathibodi Hospital Bangkok, Thailand. On Wed, 29 Jul 2009 10:26:34 -0500, Dr. Carlos Cuello wrote: >Hello everyone > >I did not understand tweeter until I finally make use of it; I thought it >was for teenagers and actually i was feeling old already. I was wrong. Mean >age of tweeter users is above 31. Rapid share of information and news has >been really helpful to me, some say is replacing the RSS. > >I do not think it will replace e-mail groups or social networking like >facebook. But it is really interesting using it when you do not have time to >write large mails and news. You only pass the info and you could save it for >latter or read it if you have time. > >My point is > >I am looking for "tweeple" (people + tweeter) to follow and follow me. > >If someone in the group uses tweeter here is my account > >http://twitter.com/CharlieNeck > >It would be nice to see you on a day by day basis, to share info and news, >and after that we could post here in the jisc-mail > >What do you think? > > > >Carlos A. Cuello-Garcํa, MD >Director, Centre for Evidence-Based Practice-Tecnologico de Monterrey >Cochrane-ITESM coordinator. Professor of Paediatrics and Clinical Research >Avda. Morones Prieto 3000 pte. Col. Doctores. CITES 3er. piso,Monterrey NL, >M้xico. CP64710 >Phone. +52(81)88882154 & 2141. Fax: +52(81)88882019 >www.cmbe.net <http://www.cmbe.net> > >The content of this data transmission must not be considered an offer, >proposal, understanding or agreement unless it is confirmed in a document >signed by a legal representative of ITESM. The content of this data >transmission is confidential and is intended to be delivered only to the >addressees. Therefore, it shall not be distributed and/or disclosed through >any means without the authorization of the original sender. If you are not >the addressee, you are forbidden from using it, either totally or partially, >for any purpose >